The Food and Drug Administration (FDA) has authorized Ruxolitinib (Opzelura)...
Leggi tuttoAlopecia Areata (AA) is an organ-specific autoimmune disorder that targets anagen phase hair follicles....
Leggi tuttoLa Food and Drug Administration (FDA) degli Stati Uniti ha approvato calcipotriene 0,005% formulato in schiuma, commercializzato da Mayne Pharma Group, per il trattamento della psoriasi a placche del cuoio capelluto e del corpo negli a...
Leggi tuttoNon è escluso che gli uffici di rappresentanza della Food and drug administration nel Regno Unito si spostino in Olanda per mantenere la vicinanza con Ema...
Leggi tuttoStudi clinici hanno mostrato che l’uso di anticorpi monoclonali riesce a ridurre i gravi effetti di questa malattia cronica della pelle...
Leggi tuttoThe US Food and Drug Administration (FDA) has approved dupilumab (Dupixent) injection to treat adults with moderate-to-severe atopic dermatitis....
Leggi tuttoThe US Food and Drug Administration (FDA) has granted accelerated approval to avelumab (Bavencio) for the treatment of patients aged 12 years and older with metastatic Merkel cell carcinoma (MCC)....
Leggi tuttoThe US Food and Drug Administration (FDA) granted accelerated approval to pembrolizumab (Keytruda) for the treatment of adult and paediatric patients with refractory classical Hodgkin lymphoma (cHL), or those who have relapsed after 3 ...
Leggi tuttoPatients were able to tolerate treatment of their rosacea with topical 1% oxymetazoline hydrochloride gel for 1 year with acceptable reduction of redness and few adverse events, according to a study presented here at the 75th Annual Me...
Leggi tuttoThe US Food and Drug Administration (FDA) has approved brodalumab (Siliq) to treat adults with moderate-to-severe plaque psoriasis. Brodalumab is administered as an injection....
Leggi tuttoThe US Food and Drug Administration (FDA) has approved crisaborole (Eucrisa) ointment to treat atopic dermatitis in patients aged 2 years and older....
Leggi tuttoThe US Food and Drug Administration (FDA) is investigating the risk of serious burns and potential permanent scarring with the use of sumatriptan iontophoretic transdermal system patch (Zecuity) for migraine headaches...
Leggi tuttoLa Food and Drug Administration (Fda) ha autorizzato l'uso di reslizumab nella terapia di mantenimento dell'asma grave in soggetti di 18 anni e più già in trattamento con altri farmaci...
Leggi tuttoThe US Food and Drug Administration (FDA) has approved ixekizumab (Taltz) for the treatment of adults with moderate-to-severe plaque psoriasis...
Leggi tuttoThe US Food and Drug Administration (FDA) has granted accelerated approval to nivolumab (Opdivo) in combination with ipilimumab for the treatment of patients with BRAF V600 wild-type, unresectable or metastatic melanoma...
Leggi tuttoThe US Food and Drug Administration (FDA) is warning that chemical leukoderma may occur with use of the methylphenidate transdermal system (Daytrana patch) for attention-deficit/hyperactivity disorder...
Leggi tuttoFor young, healthy women taking spironolactone to treat hormonal acne, frequent office visits and blood draws are an unnecessary health care expense...
Leggi tuttoLa Food and Drug Administration (FDA - Agenzia per gli Alimenti e i Medicinali), l'ente regolatorio statunitense, ha fornito un'approvazione accelerata al farmaco Nivolumab, di Bristol-Myers Squibb, per uso endovenoso. L'accelerazione ...
Leggi tuttoThe US Food and Drug Administration (FDA) today approved nivolumab (Opdivo) for the treatment of patients with unresectable or metastatic melanoma who no longer respond to other drugs...
Leggi tuttoThe US Food and Drug Administration (FDA) is warning healthcare professionals that the antipsychotic drug ziprasidone (Geodon) is associated with a rare but serious skin reaction that can progress to affect other parts of the body...
Leggi tuttoRisultati da 1 a 20 di 29